Vaccines,
Journal Year:
2022,
Volume and Issue:
10(10), P. 1736 - 1736
Published: Oct. 17, 2022
Background:
The
waning
vaccine
immunity
and
emergence
of
new
variants
SARS-CoV-2
led
health
authorities
across
the
globe
to
administer
booster
doses
(BDs)
COVID-19
vaccine.
Hence,
current
study
aimed
assess
hesitancy
(VBH)
amongst
Pakistani
healthcare
professionals
(HCPs).
Methods:
A
nationwide
survey-based
was
carried
out
from
April
2022
May
2022.
online
self-administered
questionnaire
utilized
collect
data
regarding
demographics
(age,
gender,
marital
status,
profession,
residential
area,
province),
infection
history
(infection
history,
onset,
clinical
severity
disease),
previous
vaccination
(type
number
doses),
attitudes
towards
BDs
(acceptance,
rejection,
hesitancy),
psychological
drivers
VBH
(perceived
effectiveness,
safety,
risk/benefit
ratio,
type
preference).
We
assessed
association
between
dependent
variable
participants,
independent
variables
(demographics,
vaccination,
VBH),
by
using
Chi-square
test/Fisher
exact
test.
Results:
Among
1164
51.4%
were
male,
80.4%
medical
professionals.
half
participants
(52.1%)
agreed
take
BD
or
had
already
taken
it,
while
rest
them
refused
(34.7%)
hesitated
(24.2%)
it.
These
significantly
associated
(p
<
0.001)
with
divers
about
BD.
Conclusion:
This
revealed
that
HCPs
hesitant
concerns
efficacy,
risk/benefits
ratio
vaccine’s
To
eliminate
hesitancy,
in
HCPs,
certain
educational
strategies
should
be
implemented
address
HCPs.
BMC Primary Care,
Journal Year:
2022,
Volume and Issue:
23(1)
Published: April 15, 2022
Factors
affecting
COVID-19
vaccine
acceptance
and
hesitancy
among
primary
healthcare
workers
(HCW)
remain
poorly
understood.
This
study
aims
to
identify
factors
associated
with
HCW.
Frontiers in Public Health,
Journal Year:
2022,
Volume and Issue:
10
Published: July 25, 2022
Since
healthcare
professionals
(HCPs)
play
a
critical
role
in
shaping
their
local
communities'
attitudes
toward
vaccines,
HCPs'
beliefs
and
vaccination
are
of
vital
importance
for
primary
prevention
strategies.
The
present
study
was
designed
as
cross-sectional
survey-based
utilizing
self-administered
questionnaire
to
collect
data
about
COVID-19
vaccine
booster
hesitancy
(VBH)
among
Polish
HCPs
students
medical
universities
(MUSs).
Out
the
443
included
participants,
76.3%
were
females,
52.6%
HCPs,
31.8%
previously
infected
by
SARS-CoV-2,
69.3%
had
already
received
doses
(VBD).
Overall,
74.5%
participants
willing
receive
VBD,
while
7.9
17.6%
exhibited
hesitance
rejection,
respectively.
most
commonly
found
promoter
acceptance
protection
one's
health
(95.2%),
followed
family's
(81.8%)
community's
(63.3%).
Inferential
statistics
did
not
show
significant
association
between
VBH
demographic
variables,
e.g.,
age
gender;
however,
who
been
SARS-CoV-2
significantly
more
inclined
reject
VBD.
Protection
from
severe
infection,
community
transmission,
good
safety
profile,
favorable
risk-benefit
ratio
determinants
VBD
uptake.
Fear
post-vaccination
side
effects
one
key
barriers
accepting
which
is
consistent
with
pre-existing
literature.
Public
campaigns
need
highlight
postulated
benefits
vaccines
expected
harms
skipping
Tropical Medicine and Infectious Disease,
Journal Year:
2023,
Volume and Issue:
8(3), P. 159 - 159
Published: March 5, 2023
As
the
COVID-19
pandemic
continues
and
transitions
to
an
endemic
stage,
booster
vaccines
will
play
important
role
in
personal
public
health.
However,
convincing
people
take
boosters
be
a
key
obstacle.
This
study
systematically
analyzed
research
that
examined
predictors
of
vaccine
hesitancy.
A
search
PubMed,
Medline,
CINAHL,
Web
Science,
Scopus
uncovered
42
eligible
studies.
Globally,
average
vaccination
hesitancy
rate
was
30.72%.
Thirteen
factors
influencing
emerged
from
literature:
demographics
(gender,
age,
education,
income,
occupation,
employment
status,
ethnicity,
marital
status),
geographical
influences
(country,
region,
residency),
adverse
events,
perceived
benefit/efficacy,
susceptibility,
severity,
prior
history
infection,
recommendations,
health
knowledge
information,
skepticism/distrust/conspiracy
theories,
type.
Vaccine
communication
campaigns
interventions
for
COVID
should
focus
on
confidence,
complacency,
convenience.
International Journal of Environmental Research and Public Health,
Journal Year:
2022,
Volume and Issue:
19(15), P. 8942 - 8942
Published: July 22, 2022
Background:
COVID-19
vaccines
were
made
available
to
the
public
by
end
of
2020.
However,
little
is
known
about
booster
dose
(CBD)
vaccine
perception
among
healthcare
workers
(HCW)
worldwide.
The
present
study
aims
assess
CBD
in
India
and
Saudi
Arabia
(SA).
Methods:
A
cross-sectional
was
conducted
HCWs
two
countries,
SA.
Data
gathered
through
use
a
self-administered
questionnaire.
convenience
sampling
technique
utilized
collect
data.
Results:
total
833
HCW
responses
collected
from
with
530
participants
303
SA
responding
Among
them,
16%
33%
unwilling
take
(p
<
0.005).
primary
reasons
for
not
being
willing
concerns
whether
would
be
effective
(32%)
probable
long-term
side
effects
(31%).
Concerns
knowing
enough
vaccination
(30%)
possibility
(28%)
Regression
analysis
showed
that
males,
urban
residents,
post-graduates
more
CBD.
Conclusion:
There
good
some
hesitancy
receiving
both
countries.
introduction
personalized
education,
risk
communication,
deliberate
policy
could
help
reduce
number
people
who
are
shot.
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(3), P. 623 - 623
Published: March 9, 2023
While
considerable
evidence
supports
the
safety
and
efficacy
of
COVID-19
vaccines,
a
sizable
population
expresses
vaccine
hesitancy.
As
per
World
Health
Organization,
hesitancy
is
one
top
10
hazards
to
global
health.
Vaccine
varies
across
countries,
with
India
reporting
least
was
higher
toward
booster
doses
than
previous
shots.
Therefore,
identifying
factors
determining
hesitance
(VBH)
sine
qua
non
successful
vaccination
campaign.This
systematic
review
followed
Preferred
Reporting
Items
for
Systematic
Reviews
Meta-analysis
(PRISMA)
2020
standards.
A
total
982
articles
were
pooled
from
Scopus,
PubMed
Embase,
while
42
that
addressed
VBH
finally
included
further
analysis.We
identified
responsible
divided
them
into
three
major
groups:
sociodemographic,
financial,
psychological.
Hence,
17
stated
age
be
factor
hesitancy,
most
reports
suggesting
negative
correlation
between
fear
poor
outcomes.
Nine
studies
found
females
expressing
greater
males.
Trust
deficit
in
science
(n
=
14),
concerns
about
12),
lower
levels
regarding
infection
11),
worry
side
effects
8)
also
reasons
Blacks,
Democrats,
pregnant
women
showed
high
Few
have
income,
obesity,
social
media,
living
vulnerable
members
as
influencing
study
44.1%
towards
could
attributed
dominantly
low
rural
origin,
previously
unvaccinated
status,
or
individuals.
However,
two
other
Indian
reported
lack
availability
slots,
trust
government,
doses.Many
confirmed
multifactorial
nature
VBH,
which
necessitates
multifaceted,
individually
tailored
interventions
address
all
potentially
modifiable
factors.
This
chiefly
recommends
strategizing
campaign
by
evaluating
appropriate
communication
(at
both
individual
community
levels)
benefits
risk
losing
immunity
without
them.
Journal of Clinical Nursing,
Journal Year:
2022,
Volume and Issue:
32(13-14), P. 3943 - 3953
Published: Nov. 7, 2022
Abstract
Aims
and
objectives
To
assess
the
levels
of
second
COVID‐19
booster
dose/new
vaccine
hesitancy
among
nurses
explore
potential
predictors
hesitancy.
Background
full
vaccination
seems
to
be
highly
effective
against
contagious
variants
SARS‐CoV‐2.
Healthcare
workers
are
at
high‐risk
group
since
they
have
experienced
high
COVID‐19‐associated
morbidity
mortality.
Design
An
on‐line
cross‐sectional
study
was
carried
out
in
Greece
May
2022,
using
a
self‐administered
questionnaire.
Methods
The
population
included
healthcare
services
who
were
fully
vaccinated
time
study.
We
considered
socio‐demographic
characteristics,
COVID‐19‐related
variables,
attitudes
toward
pandemic
as
applied
STROBE
checklist
our
Results
Among
795
nurses,
30.9%
hesitant
dose
or
new
vaccine.
Independent
lower
educational
level,
absence
chronic
condition,
good/very
good
self‐perceived
physical
health,
lack
flu
during
2021,
front‐line
that
provided
patients,
had
not
been
diagnosed
with
least
one
relative/friend
has
died
from
COVID‐19.
Moreover,
increased
compliance
hygiene
measures,
fear
decreased
trust
associated
Conclusions
Our
shows
significant
percentage
This
initial
could
barrier
efforts
control
pandemic.
Relevance
clinical
practice
Nurses'
role
is
essential
empowering
public
their
passion
empathy.
There
need
communicate
science
way
accessible
order
decrease
Patient
contribution
No
patient
contribution.
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(2), P. 385 - 385
Published: Feb. 7, 2023
Attitudes
of
healthcare
workers
(HCWs)
toward
vaccines
are
extremely
important
for
increasing
vaccination
coverage.
We
conducted
a
cross-sectional
study
at
the
beginning
fourth
COVID-19
dose
campaign
among
124
HCWs
to
evaluate
attitudes
towards
and
willingness
get
vaccinated.
At
that
time,
Israel
was
first
country
approve
vaccine
dose.
Most
women
were
unwilling
compared
men;
53.9%
physicians
vaccinated
83.3%
nurses
69%
other
professions.
The
most
frequent
concerns
regarding
its
efficacy,
benefit,
necessity.
perceived
risk
severity
health
involved
with
getting
higher
who
stated
they
would
not
those
or
intended
In
contrast,
dose,
planning
vaccinated,
gave
scores
benefit
booster,
advantages,
safety,
ability
protect
from
severe
illness,
extent
scientific
information
about
associated
booster.
A
logistic
regression
model
revealed
perception
dose's
benefits
significantly
predict
Willingness
vaccinate
their
own
children,
acceptance
hypothetical
annual
booster
vaccine,
having
less
adverse
effects
after
prior
also
These
findings
could
help
policy
makers
in
developing
strategies
expand
coverage
doses.
Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 27, 2024
Healthcare
workers
(HCWs)
are
role
models
in
their
communities.
If
they
receive
the
COVID-19
vaccine,
many
people
likely
to
follow
and
have
vaccine.
HCWs
hesitant
or
resistant
taking
this
may
impede
efforts
implement
reach
herd
immunity,
eliminate
pandemic.
In
narrative
review,
we
reviewed
previous
studies
on
hesitancy
over
vaccination
among
different
healthcare
professions
medical
field,
such
as
primary
HCWs,
dentists,
nurses,
students.
We
common
reasons
associated
factors
for
toward
vaccine
professions.
The
following
keywords
were
used
database
search:
AND
workers.
searched
articles
using
PubMed,
Scopus,
Google
Scholar
databases.
found
HCW
with
various
rates
of
hesitancy,
including
center
(PHC)
(50%),
students
(45%),
nurses
(21%),
dentists
(18%).
Hesitancy
booster
doses
was
also
who
had
taken
(2.8%
26%).
Race
ethnicity
influenced
rates,
Black
individuals
being
most
group.
concerns
about
safety
adverse
effects
insufficient
information,
a
lack
confidence
policies.
Despite
varying
after
vaccine's
release,
is
expected
negatively
affect
achieve
widespread
vaccination.
recommendations
policymakers
address
these
raising
awareness
PHC
doctors
because
easiest
first
line
patient
improving
communication
through
all
channels
(e.g.,
webinars,
e-mails,
social
media),
inviting
online
meetings
workshops
so
can
listen
recommendations.
Correctly
addressing
issue
HCWs'
support
contain
Vaccine X,
Journal Year:
2024,
Volume and Issue:
18, P. 100480 - 100480
Published: March 23, 2024
The
global
deployment
of
COVID-19
vaccine
booster
dose
(VBD)
has
been
recognized
as
a
promising
therapeutic
alliance
to
provide
repeated
immunity
against
the
arrival
new
variants.
Despite
scientific
evidence
supports
effectiveness
periodic
doses,
reluctance
continues
thrive.
This
narrative
review
aimed
examine
doses
acceptance
and
summarize
an
up-to-date
assessment
potential
antecedents
associated
with
VBD
acceptance.
A
comprehensive
search
was
performed
in
several
reputable
databases
such
Medline
(via
PubMed),
Scopus,
Google
scholar,
Web
Science
from
June
10th,
2023,
August
1st,
2023.
All
relevant
descriptive
observational
studies
on
hesitancy
were
included
this
review.
total
fifty-eight
(58)
included,
Asia
representing
highest
count
thirty-one
(53
%)
studies,
Europe
eleven
(19
%),
United
States
nine
(16
other
regions
(Africa
multi-ethnic)
seven
(12
%).
Worldwide,
pooled
rate
77.09
%
(95
CI:
76.28–78.18),
willingness
(n)
=
164189,
sample
(N)
212,990.
lowest
reported
American
regions,
respectively,
85.38
85.02–85.73,
32,047,
(N
37,533)
vs.
66.92
66.56–67.4),
29335,
43,832.
However,
multi-ethnic
areas
moderately
high
79.13
78.77–79.23,
93,994,
11,8779)
72.16
71.13–72.93,
9276,
12,853),
respectively.
most
common
key
across
countries
"equal
safety",
"efficacy",
"effectiveness",
post-vaccination
"side
effects",
"community
protection"
"family
protection",
"risk-benefit
ratio",
necessity",
"trust,
"variants
control".
Disparities
uptake
observed
globally,
rates
found
Europe,
regions.
Multiple
including
safety,
efficacy,
side
effects
hesitancy.
BMC Health Services Research,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: March 6, 2025
Despite
completing
the
COVID-19
vaccination
series,
healthcare
workers
(HCWs)
remain
at
an
elevated
risk
of
re-infection.
Booster
uptake,
though
essential
for
this
group,
remains
poorly
characterized
among
Bangladeshi
HCWs.
This
study
identified
prevalence
and
driving
factors
behind
booster
hesitancy
HCWs,
providing
valuable
insights
targeted
interventions.
From
December
2022
to
June
2023,
we
conducted
a
cross-sectional
survey
1772
HCWs
enrolled
from
20
facilities
all
tiers
purposively
selected
across
four
administrative
divisions
Bangladesh.
We
collected
information
through
face-to-face
interviews
regarding
their
sociodemographic,
pre-existing,
currently
existing
medical
conditions,
status,
intention,
hesitancy,
willingness
receive
future
doses.
used
multivariable
logistic
regression
model
analyze
associated
with
hesitancy.
Odd's
ratio
95%
confidence
intervals
(CIs)
was
calculated
each
factor,
p
<
0.05
considered
statistically
significant.
Of
interviewed
in
our
study,
49%
(879)
were
nurses
[median
age
36
years
(IQR:
30.0-46.0)];
69%
female.
Among
respondents,
94%
(1667)
willing
take
booster,
6%
(105)
showed
Safety
concerns,
especially
potential
side
effects
post-booster
administration
(86%),
emerged
as
leading
cause
workers.
Our
analysis
revealed
that
support
staff,
compared
physicians,
most
hesitant
any
additional
dose
(aOR
4.68,
CI:
1.56-9.03;
p=0.006).
Compared
rural
residency,
urban
residency
type
also
more
reluctant
doses
4.45,
2.03-9.73;
0.001).
Concerns
about
following
primary
driver
study.
Targeted
interventions
focusing
on
education
addressing
these
anxieties-supported
by
evidence-based
communication
strategies-could
play
crucial
role
improving
acceptance
safeguarding
vulnerable
workforce.